Advertisement

Interactions of Normal Tissues and Systems with Metastatic Cells: Impact on Location, Survival and Growth

Chapter

Abstract

Tumor formation is not a cell autonomous phenomenon, but rather an evolution of disease within and responding to the host environment. In particular, metastatic spread from a primary tumor results from a complex interplay between tumor cells and the host. In order to form successful metastases, tumor cells must escape the primary tumor, enter the host vasculature, travel to and arrest in a distant tissue and survive and grow in that new organ. Cells that progress through these stages must both escape and exploit host systems.

Keywords

Melanoma Cell Metastatic Cell B16F1 Cell Pulmonary Vasculature Squamous Cell Carcinoma Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

We would like to thank Kyle MacLean for his assistance with figure design. JMK is the recipient of a Translational Breast Cancer Studentship from the London Regional Cancer Program. AFC is a Cancer Research Chair in Oncology and receives salary support from the Canada Research Chairs Program.

References

  1. Abramsson A, Lindblom P, Betsholtz C (2003) Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. J Clin Invest 112:1142–1151PubMedGoogle Scholar
  2. Al-Mehdi AB et al (2000) Intravascular origin of metastasis from the proliferation of endothelium-attached tumor cells: a new model for metastasis. Nat Med 6:100–102PubMedCrossRefGoogle Scholar
  3. Bach F, Uddin FJ, Burke D (2007) Angiopoietins in malignancy. Eur J Surg Oncol 33:7–15PubMedCrossRefGoogle Scholar
  4. Barbera-Guillem E, Nyhus JK, Wolford CC, Friece CR, Sampsel JW (2002) Vascular endothelial growth factor secretion by tumor-infiltrating macrophages essentially supports tumor angiogenesis, and IgG immune complexes potentiate the process. Cancer Res 62:7042–7049PubMedGoogle Scholar
  5. Bissell MJ, Radisky DC, Rizki A, Weaver VM, Petersen OW (2002) The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 70:537–546PubMedCrossRefGoogle Scholar
  6. Borsig L (2008) The role of platelet activation in tumor metastasis. Expert Rev Anticancer Ther 8:1247–1255PubMedCrossRefGoogle Scholar
  7. Brooks SA, Lomax-Browne HJ, Carter TM, Kinch CE, Hall DM (2010) Molecular interactions in cancer cell metastasis. Acta Histochem 112:3–25PubMedCrossRefGoogle Scholar
  8. Byrne AM, Bouchier-Hayes DJ, Harmey JH (2005) Angiogenic and cell survival functions of vascular endothelial growth factor (VEGF). J Cell Mol Med 9:777–794PubMedCrossRefGoogle Scholar
  9. Cameron MD et al (2000) Temporal progression of metastasis in lung: cell survival, dormancy, and location dependence of metastatic inefficiency. Cancer Res 60:2541–2546PubMedGoogle Scholar
  10. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4–10PubMedCrossRefGoogle Scholar
  11. Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257PubMedCrossRefGoogle Scholar
  12. Chambers AF, Groom AC, MacDonald IC (2002) Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2:563–572PubMedCrossRefGoogle Scholar
  13. Chung YC, Hou YC, Chang CN, Hseu TH (2006) Expression and prognostic significance of angiopoietin in colorectal carcinoma. J Surg Oncol 94:631–638PubMedCrossRefGoogle Scholar
  14. Direkze NC et al (2004) Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res 64:8492–8495PubMedCrossRefGoogle Scholar
  15. Duffy MJ, McGowan PM, Gallagher WM (2008) Cancer invasion and metastasis: changing views. J Pathol 214:283–293PubMedCrossRefGoogle Scholar
  16. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146:1029–1039PubMedGoogle Scholar
  17. Esumi N, Fan D, Fidler IJ (1991) Inhibition of murine melanoma experimental metastasis by recombinant desulfatohirudin, a highly specific thrombin inhibitor. Cancer Res 51:4549–4556PubMedGoogle Scholar
  18. Etoh T et al (2001) Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases. Cancer Res 61:2145–2153PubMedGoogle Scholar
  19. Evans R et al (1992) Tumor cell IL-6 gene expression is regulated by IL-1 alpha/beta and TNF alpha: proposed feedback mechanisms induced by the interaction of tumor cells and macrophages. J Leukoc Biol 52:463–468PubMedGoogle Scholar
  20. Fischer EG et al (1999) Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor. J Clin Invest 104:1213–1221PubMedCrossRefGoogle Scholar
  21. Folkman J (1995) Angiogenesis inhibitors generated by tumors. Mol Med 1:120–122PubMedGoogle Scholar
  22. Gaggioli C et al (2007) Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 9:1392–1400PubMedCrossRefGoogle Scholar
  23. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997) Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 277:225–228PubMedCrossRefGoogle Scholar
  24. Goswami S et al (2005) Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop. Cancer Res 65:5278–5283PubMedCrossRefGoogle Scholar
  25. Hagemann T et al (2005) Macrophages induce invasiveness of epithelial cancer cells via NF-kappa B and JNK. J Immunol 175:1197–1205PubMedGoogle Scholar
  26. Hagemann T et al. (2008) “Re-educating” tumor-associated macrophages by targeting NF-kappaB. J Exp Med 205:1261–1268PubMedCrossRefGoogle Scholar
  27. Hall K, Ran S (2010) Regulation of tumor angiogenesis by the local environment. Front Biosci 15:195–212PubMedCrossRefGoogle Scholar
  28. Harbeck N et al (2004) Urokinase-type plasminogen activator (uPA) and its inhibitor PAI-I: novel tumor-derived factors with a high prognostic and predictive impact in breast cancer. Thromb Haemost 91:450–456PubMedGoogle Scholar
  29. Harmey JH, Dimitriadis E, Kay E, Redmond HP, Bouchier-Hayes D (1998) Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1. Ann Surg Oncol 5:271–278PubMedCrossRefGoogle Scholar
  30. Hattori K et al (2001) Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med 193:1005–1014PubMedCrossRefGoogle Scholar
  31. Hlatky L, Tsionou C, Hahnfeldt P, Coleman CN (1994) Mammary fibroblasts may influence breast tumor angiogenesis via hypoxia-induced vascular endothelial growth factor up-regulation and protein expression. Cancer Res 54:6083–6086PubMedGoogle Scholar
  32. Hsu MY et al (2000) E-cadherin expression in melanoma cells restores keratinocyte-mediated growth control and down-regulates expression of invasion-related adhesion receptors. Am J Pathol 156:1515–1525PubMedCrossRefGoogle Scholar
  33. Hsu MY, Meier F, Herlyn M (2002) Melanoma development and progression: a conspiracy between tumor and host. Differentiation 70:522–536PubMedCrossRefGoogle Scholar
  34. Hu L, Roth JM, Brooks P, Luty J, Karpatkin S (2008) Thrombin up-regulates cathepsin D which enhances angiogenesis, growth, and metastasis. Cancer Res 68:4666–4673PubMedCrossRefGoogle Scholar
  35. Huang YQ, Li JJ, Hu L, Lee M, Karpatkin S (2002) Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 99:1646–1650PubMedCrossRefGoogle Scholar
  36. Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326:1216–1219PubMedCrossRefGoogle Scholar
  37. Ii M, Yamamoto H, Adachi Y, Maruyama Y, Shinomura Y (2006) Role of matrix metalloproteinase-7 (matrilysin) in human cancer invasion, apoptosis, growth, and angiogenesis. Exp Biol Med (Maywood) 231:20–27Google Scholar
  38. Im JH et al (2004) Coagulation facilitates tumor cell spreading in the pulmonary vasculature during early metastatic colony formation. Cancer Res 64:8613–8619PubMedCrossRefGoogle Scholar
  39. Janji B, Melchior C, Gouon V, Vallar L, Kieffer N (1999) Autocrine TGF-beta-regulated expression of adhesion receptors and integrin-linked kinase in HT-144 melanoma cells correlates with their metastatic phenotype. Int J Cancer 83:255–262PubMedCrossRefGoogle Scholar
  40. Kaplan RN et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438:820–827PubMedCrossRefGoogle Scholar
  41. Kedrin D et al (2008) Intravital imaging of metastatic behavior through a mammary imaging window. Nat Methods 5:1019–1021PubMedCrossRefGoogle Scholar
  42. Kienast Y et al (2010) Real-time imaging reveals the single steps of brain metastasis formation. Nat Med 16:116–122PubMedCrossRefGoogle Scholar
  43. Kim JW et al (2004) Rapid apoptosis in the pulmonary vasculature distinguishes non-metastatic from metastatic melanoma cells. Cancer Lett 213:203–212PubMedCrossRefGoogle Scholar
  44. Kim YJ, Borsig L, Varki NM, Varki A (1998) P-selectin deficiency attenuates tumor growth and metastasis. Proc Natl Acad Sci U S A 95:9325–9330PubMedCrossRefGoogle Scholar
  45. Kirstein JM et al (2009) Effect of anti-fibrinolytic therapy on experimental melanoma metastasis. Clin Exp Metastasis 26:121–131PubMedCrossRefGoogle Scholar
  46. Koop S et al (1995) Fate of melanoma cells entering the microcirculation: over 80 % survive and extravasate. Cancer Res 55:2520–2523PubMedGoogle Scholar
  47. Koop S et al (1996) Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well. Proc Natl Acad Sci U S A 93:11080–11084PubMedCrossRefGoogle Scholar
  48. Kramer MD, Reinartz J, Brunner G, Schirrmacher V (1994) Plasmin in pericellular proteolysis and cellular invasion. Invasion Metastasis 14:210–222PubMedGoogle Scholar
  49. Le Bitoux MA, Stamenkovic I (2008) Tumor-host interactions: the role of inflammation. Histochem Cell Biol 130:1079–1090PubMedCrossRefGoogle Scholar
  50. Lee JT, Herlyn M (2007) Microenvironmental influences in melanoma progression. J Cell Biochem 101:862–872PubMedCrossRefGoogle Scholar
  51. Li G. et al. (2003) Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil. Oncogene 22:3162–3171PubMedCrossRefGoogle Scholar
  52. Li G, Satyamoorthy K, Herlyn M (2001a) N-cadherin-mediated intercellular interactions promote survival and migration of melanoma cells. Cancer Res 61:3819–3825Google Scholar
  53. Li JJ, Huang YQ, Basch R, Karpatkin S (2001b) Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 85:204–206Google Scholar
  54. Lin EY, Pollard JW (2004) Role of infiltrated leucocytes in tumour growth and spread. Br J Cancer 90:2053–2058PubMedCrossRefGoogle Scholar
  55. Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411:375–379PubMedCrossRefGoogle Scholar
  56. Lorusso G, Ruegg C (2008) The tumor microenvironment and its contribution to tumor evolution toward metastasis. Histochem Cell Biol 130:1091–1103PubMedCrossRefGoogle Scholar
  57. Luzzi KJ et al (1998) Multistep nature of metastatic inefficiency: dormancy of solitary cells after successful extravasation and limited survival of early micrometastases. Am J Pathol 153:865–873PubMedCrossRefGoogle Scholar
  58. Maisonpierre PC et al (1997) Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 277:55–60PubMedCrossRefGoogle Scholar
  59. Massberg S et al (2006) Platelets secrete stromal cell-derived factor 1alpha and recruit bone marrow-derived progenitor cells to arterial thrombi in vivo. J Exp Med 203:1221–1233PubMedCrossRefGoogle Scholar
  60. McCabe NP, Selman SH, Jankun J (2006) Vascular endothelial growth factor production in human prostate cancer cells is stimulated by overexpression of platelet 12-lipoxygenase. Prostate 66:779–787PubMedCrossRefGoogle Scholar
  61. McCarty OJ, Mousa SA, Bray PF, Konstantopoulos K (2000) Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions. Blood 96:1789–1797PubMedGoogle Scholar
  62. McCourt M, Wang JH, Sookhai S, Redmond HP (1999) Proinflammatory mediators stimulate neutrophil-directed angiogenesis. Arch Surg 134:1325–1331; (discussion 1331–2)PubMedCrossRefGoogle Scholar
  63. McDonald DM, Choyke PL (2003) Imaging of angiogenesis: from microscope to clinic. Nat Med 9:713–725PubMedCrossRefGoogle Scholar
  64. Melnikova VO, Bar-Eli M (2009) Inflammation and melanoma metastasis. Pigment Cell Melanoma Res 22:257–267PubMedCrossRefGoogle Scholar
  65. Milner CS, Hansen TM, Singh H, Brindle NP (2009) Roles of the receptor tyrosine kinases Tie1 and Tie2 in mediating the effects of angiopoietin-1 on endothelial permeability and apoptosis. Microvasc Res 77:187–191PubMedCrossRefGoogle Scholar
  66. Mohle R, Green D, Moore MA, Nachman RL, Rafii S (1997) Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A 94:663–668PubMedCrossRefGoogle Scholar
  67. Nakamura Y et al (2008) PDGF-BB is a novel prognostic factor in colorectal cancer. Ann Surg Oncol 15:2129–2136PubMedCrossRefGoogle Scholar
  68. Nakayama T et al (2005) Expression and significance of Tie-1 and Tie-2 receptors, and angiopoietins-1, 2 and 4 in colorectal adenocarcinoma: Immunohistochemical analysis and correlation with clinicopathological factors. World J Gastroenterol 11:964–969PubMedGoogle Scholar
  69. Naumov GN, Folkman J, Straume O, Akslen LA (2008) Tumor-vascular interactions and tumor dormancy. Apmis 116:569–585PubMedCrossRefGoogle Scholar
  70. Nierodzik ML, Karpatkin S (2006) Thrombin induces tumor growth, metastasis, and angiogenesis: Evidence for a thrombin-regulated dormant tumor phenotype. Cancer Cell 10:355–362PubMedCrossRefGoogle Scholar
  71. Nieto MA (2002) The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 3:155–166PubMedCrossRefGoogle Scholar
  72. Nilsson I, Shibuya M, Wennstrom S (2004) Differential activation of vascular genes by hypoxia in primary endothelial cells. Exp Cell Res 299:476–485PubMedCrossRefGoogle Scholar
  73. Noguera-Troise I et al (2006) Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis. Nature 444 1032–1037PubMedCrossRefGoogle Scholar
  74. Nonomura N et al (2007) Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer 97:952–956PubMedGoogle Scholar
  75. Olumi AF et al (1999) Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Res 59:5002–5011PubMedGoogle Scholar
  76. Orimo A, Weinberg RA (2006) Stromal fibroblasts in cancer: a novel tumor-promoting cell type. Cell Cycle 5:1597–1601PubMedCrossRefGoogle Scholar
  77. Palumbo JS et al (2000) Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells. Blood 96:3302–3309PubMedGoogle Scholar
  78. Palumbo JS et al (2002) Spontaneous hematogenous and lymphatic metastasis, but not primary tumor growth or angiogenesis, is diminished in fibrinogen-deficient mice. Cancer Res 62:6966–6972PubMedGoogle Scholar
  79. Palumbo JS et al (2005) Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. Blood 105:178–185PubMedCrossRefGoogle Scholar
  80. Palumbo JS et al (2007) Tumor cell-associated tissue factor and circulating hemostatic factors cooperate to increase metastatic potential through natural killer cell-dependent and-independent mechanisms. Blood 110:133–141PubMedCrossRefGoogle Scholar
  81. Palumbo JS et al (2008) Factor XIII transglutaminase supports hematogenous tumor cell metastasis through a mechanism dependent on natural killer cell function. J Thromb Haemost 6:812–819PubMedCrossRefGoogle Scholar
  82. Palumbo JS, Degen JL (2007) Mechanisms linking tumor cell-associated procoagulant function to tumor metastasis. Thromb Res 120(Suppl 2):S22–8PubMedCrossRefGoogle Scholar
  83. Pirila E et al (2003) Matrix metalloproteinases process the laminin-5 gamma 2-chain and regulate epithelial cell migration. Biochem Biophys Res Commun 303:1012–1017PubMedCrossRefGoogle Scholar
  84. Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 4:71–78PubMedCrossRefGoogle Scholar
  85. Qian B et al (2009) A distinct macrophage population mediates metastatic breast cancer cell extravasation, establishment and growth. PLoS One 4:e6562PubMedCrossRefGoogle Scholar
  86. Qiu H et al. (2003) Arrest of B16 melanoma cells in the mouse pulmonary microcirculation induces endothelial nitric oxide synthase-dependent nitric oxide release that is cytotoxic to the tumor cells. Am J Pathol 162:403–412PubMedCrossRefGoogle Scholar
  87. Rak J, Milsom C, Magnus N, Yu J (2009) Tissue factor in tumour progression. Best Pract Res Clin Haematol 22:71–83PubMedCrossRefGoogle Scholar
  88. Reijerkerk A, Voest EE, Gebbink MF (2000) No grip, no growth: the conceptual basis of excessive proteolysis in the treatment of cancer. Eur J Cancer 36:1695–1705PubMedCrossRefGoogle Scholar
  89. Ribatti D, Mangialardi G, Vacca A (2006) Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination. Clin Exp Med 6:145–149PubMedCrossRefGoogle Scholar
  90. Robinson BD et al (2009) Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination. Clin Cancer Res 15:2433–2441PubMedCrossRefGoogle Scholar
  91. Robinson SC, Coussens LM (2005) Soluble mediators of inflammation during tumor development. Adv Cancer Res 93:159–187PubMedCrossRefGoogle Scholar
  92. Ruzinova MB et al (2003) Effect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumors. Cancer Cell 4:277–289PubMedCrossRefGoogle Scholar
  93. Shi X, Gangadharan B, Brass LF, Ruf W, Mueller BM (2004) Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2:395–402PubMedGoogle Scholar
  94. Sounni NE et al (2010) Stromal regulation of vessel stability by MMP14 and TGFbeta. Dis Model Mech 3:317–332PubMedCrossRefGoogle Scholar
  95. Suchting S et al (2007) The Notch ligand Delta-like 4 negatively regulates endothelial tip cell formation and vessel branching. Proc Natl Acad Sci U S A 104:3225–3230PubMedCrossRefGoogle Scholar
  96. Tait CR, Jones PF (2004) Angiopoietins in tumours: the angiogenic switch. J Pathol 204:1–10PubMedCrossRefGoogle Scholar
  97. Takeichi M (1993) Cadherins in cancer: implications for invasion and metastasis. Curr Opin Cell Biol 5:806–811PubMedCrossRefGoogle Scholar
  98. Taskinen M, Karjalainen-Lindsberg ML, Leppa S (2008) Prognostic influence of tumor-infiltrating mast cells in patients with follicular lymphoma treated with rituximab and CHOP. Blood 111:4664–4667PubMedCrossRefGoogle Scholar
  99. Teti A et al (1997) Transforming growth factor-beta enhances adhesion of melanoma cells to the endothelium in vitro. Int J Cancer 72:1013–1020PubMedCrossRefGoogle Scholar
  100. Timar J et al (2005) Platelet-mimicry of cancer cells: epiphenomenon with clinical significance. Oncology 69:185–201PubMedCrossRefGoogle Scholar
  101. Wang F et al (2002) Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contexts. J Natl Cancer Inst 94:1494–1503PubMedCrossRefGoogle Scholar
  102. Wang HH et al (2000) B16 melanoma cell arrest in the mouse liver induces nitric oxide release and sinusoidal cytotoxicity: a natural hepatic defense against metastasis. Cancer Res 60:5862–5869PubMedGoogle Scholar
  103. Weaver VM et al. (1997) Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 137:231–245PubMedCrossRefGoogle Scholar
  104. Wong CW et al (2002) Intravascular location of breast cancer cells after spontaneous metastasis to the lung. Am J Pathol 161:749–753PubMedCrossRefGoogle Scholar
  105. Wu Y et al (2009) Stabilization of snail by NF-kappaB is required for inflammation-induced cell migration and invasion. Cancer Cell 15:416–428PubMedCrossRefGoogle Scholar
  106. Wyckoff J et al (2004) A paracrine loop between tumor cells and macrophages is required for tumor cell migration in mammary tumors. Cancer Res 64:7022–7029PubMedCrossRefGoogle Scholar
  107. Wyckoff JB et al (2007) Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors. Cancer Res 67:2649–2656PubMedCrossRefGoogle Scholar
  108. Zhang Q. et al (2010) The role of the intravascular microenvironment in spontaneous metastasis development. Int J Cancer 126:2534–2541PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Medical BiophysicsUniversity of Western OntarioLondonCanada
  2. 2.Departments of Oncology, Medical Biophysics, and PathologyUniversity of Western OntarioLondonCanada

Personalised recommendations